Loading patent…
AssigneesAmpX Technologies, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
InventorsAmir Hossein Gandjbakhche, Thien T. Nguyen, Zeyu Zhang, Soongho Park, George H. Downey, Alireza Khaligh, Kosar Khaksari
Estimating the term…
The disclosure provides systems and a protocol for monitoring the health of a fetus and a mother during pregnancy. A wearable device utilizing near-infrared spectroscopy (NIRS) is disclosed for monitoring a number of parameters associated with placental tissue, the fetus, and/or the mother. The device includes one or more light sources and one or more photodetectors, each photodetector separated from a particular light source by a corresponding separation distance. The device further includes a processor configured to collect data based on intensity information collected by the plurality of photodetectors responsive to activation of one or more of the plurality of light sources. The data is used to estimate an oxygen saturation level for a layer of placental tissue in a uterus of a mother, or maternal physiological signals including respiratory functions, cardiac functions, oxygenation levels, or fetal cardiac functions.
An apparatus, comprising:
A system for monitoring a health of a mother or fetus during pregnancy, the system comprising:
A method for monitoring a health of a mother or fetus during pregnancy, the method comprising:
Dependencies are inferred from the claim text.